|
|
|
Regulatory Input to Drug Development
- Development of Target Product Profile
- Non Clinical and Clinical Development Plans
- Global Regulatory Strategy
- Data Gap Analyses
- Regulatory Due Diligence
- Regulatory Agency Consultations: Pharmaceutical, Non Clinical and Clinical Development
- Orphan Drug Designation
- Paediatric Development Program
|
|
|
|
|
|
|
|
|
|
|
